Dinaline

Drug Profile

Dinaline

Alternative Names: AAPBA; GOE 1734; NSC 328786; PD 104208

Latest Information Update: 30 Jul 1998

Price : $50

At a glance

  • Originator Goedecke
  • Developer Goedecke; Nonindustrial source
  • Class Aniline compounds; Antineoplastics; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 30 Jul 1998 Discontinued-Preclinical for Cancer in Germany (Unknown route)
  • 16 Jan 1997 A preclinical study has been added to the Cancer pharmacodynamics section
  • 16 Jan 1997 Preclinical development for Cancer in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top